Posted On June 16, 2022 Consumer Privacy & Data Breaches
June 16, 2022 – Acorda Therapeutics, Inc reported a data breach after the company was targeted in a recent cybersecurity attack. As a result of the breach, the name or other personal identifier in combination with: Social Security Number of certain individuals was compromised. The Acorda Therapeutics data breach is believed to have impacted as many as 1,593 individuals. On June 10, 2022, Acorda Therapeutics sent out data breach letters to those individuals whose information was affected by the breach.
The data breach lawyers at Console & Associates, P.C. are going to begin interviewing victims of the breach to determine what damages they sustained and what legal claims may be available to them. If you recently received a NOTICE OF DATA BREACH from Acorda Therapeutics, Inc, contact us at (866) 778-5500 to discuss your legal options, or submit a confidential contact form for a free case evaluation.
Below is a portion of the letter that Acorda Therapeutics, Inc sent to individuals affected by the data breach:
Dear [Redacted],
Acorda Therapeutics, Inc. (“Company”) writes to notify you of a security incident that may affect the privacy of some of your information. This letter provides details of the incident, our response, and steps you may take to better protect against possible misuse of your information, should you feel it appropriate to do so.
What Happened?
In January 2022, we became aware of suspicious activity related to our business email environment. We immediately took steps to secure the email environment and launched an investigation to determine the full nature and scope of this activity. Our investigation determined that an unknown actor gained access to certain Company emails on or around December 15, 2021. We began reviewing the contents of the potentially affected emails to determine what, if any, sensitive information may have been contained therein. This process was completed on April 27, 2022. We thereafter worked to reconcile the information with our internal records to identify any individuals whose data may have been compromised and obtain their appropriate contact information. We are providing this notice to you because we understand, based on our investigation, that your information was present in an impacted email account during the period of unauthorized access.
What Information Was Involved?
We determined that the following information related to you was present in the relevant emails at the time of this incident: name and [Redacted]. While we have no evidence that any of your information was used for identity theft or fraud as a result of the event, we are notifying you out of an abundance of caution and providing information and resources to help protect your personal information, should you feel it appropriate to do so.
What We Are Doing.
We take the confidentiality, privacy, and security of information in our care seriously. Upon discovery, we immediately commenced an investigation to confirm the nature and scope of the incident. We also took immediate steps to implement additional safeguards and we continue to review our procedures and tools to improve on existing security. The Company is providing you with access to number [Redacted] months of credit monitoring and identity protection services through Experian at no cost to you. A description of services and instructions on how to enroll can be found within the enclosed Steps You Can Take To Help Protect Your Personal Information. Please note that you must complete the enrollment process yourself, as we are not permitted to enroll you in these services on your behalf.
What You Can Do.
You can review the enclosed Steps You Can Take To Help Protect Your Personal Information. You can also enroll to receive the complimentary credit monitoring and identity protection services through Experian. We also encourage you to remain vigilant against incidents of identity theft and fraud, to review your account statements, and to monitor your credit reports for suspicious activity.
For More Information.
We understand that you may have questions about this incident that are not addressed in this letter. To ensure your questions are answered in a timely manner, please contact our toll-free dedicated assistance line at (833) 281-4833. This toll-free line is available Monday – Friday from 9 am to 11 pm EDT and Saturday and Sunday from 11 am to 8 pm EDT (excluding major US holidays). Individuals may also write to Acorda Therapeutics, Inc. at 420 Saw Mill River Road Ardsley, NY 10502.
